CABOT CORP (CBT) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
47/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinCBT / S&P 21.25% / 15.20% |
LoseCBT / S&P -4.74% / 15.00% |
LoseCBT / S&P -53.40% / 50.40% |
| 2026-Q11/3 |
WinCBT / S&P 14.30% / -4.33% |
LoseCBT / S&P -8.52% / 11.30% |
LoseCBT / S&P -31.35% / 27.70% |
| 2025-Q40/3 |
LoseCBT / S&P -12.23% / 2.65% |
LoseCBT / S&P -9.62% / 9.00% |
LoseCBT / S&P -23.94% / 13.40% |
| 2025-Q30/3 |
LoseCBT / S&P 1.96% / 8.12% |
LoseCBT / S&P -7.04% / 4.61% |
LoseCBT / S&P -10.55% / 13.45% |
| 2025-Q20/3 |
LoseCBT / S&P -9.25% / 10.94% |
LoseCBT / S&P -3.61% / 4.83% |
LoseCBT / S&P -8.94% / 10.63% |
| 2025-Q10/3 |
LoseCBT / S&P -8.49% / -4.27% |
LoseCBT / S&P -0.05% / 4.98% |
LoseCBT / S&P -2.03% / 10.57% |
| 2024-Q40/3 |
LoseCBT / S&P -17.98% / 2.41% |
LoseCBT / S&P 1.71% / 5.25% |
LoseCBT / S&P -2.08% / 6.15% |
| 2024-Q31/3 |
WinCBT / S&P 22.14% / 5.89% |
LoseCBT / S&P 1.60% / 5.89% |
LoseCBT / S&P -12.94% / 6.11% |
| 2024-Q21/3 |
LoseCBT / S&P 0.09% / 4.28% |
LoseCBT / S&P -2.94% / 5.38% |
WinCBT / S&P 58.90% / 5.12% |
| 2024-Q12/3 |
WinCBT / S&P 10.96% / 10.56% |
LoseCBT / S&P -8.19% / 5.71% |
WinCBT / S&P 42.24% / 5.59% |
| 2023-Q42/3 |
WinCBT / S&P 21.17% / 11.69% |
LoseCBT / S&P -9.12% / 6.81% |
WinCBT / S&P 26.11% / 7.78% |
| 2023-Q32/3 |
WinCBT / S&P 4.16% / -3.27% |
LoseCBT / S&P -9.03% / 7.52% |
WinCBT / S&P 115.32% / -5.03% |
| 2023-Q21/3 |
LoseCBT / S&P -12.22% / 8.74% |
LoseCBT / S&P -0.85% / 9.50% |
WinCBT / S&P 114.63% / -8.57% |
| 2023-Q12/3 |
WinCBT / S&P 15.21% / 7.50% |
LoseCBT / S&P 9.74% / 10.77% |
WinCBT / S&P 146.22% / -15.69% |
| 2022-Q42/3 |
LoseCBT / S&P 5.15% / 7.56% |
WinCBT / S&P 18.92% / 11.88% |
WinCBT / S&P 256.14% / -17.99% |
| 2022-Q32/3 |
WinCBT / S&P 0.65% / -4.88% |
WinCBT / S&P 26.75% / 13.47% |
LoseCBT / S&P -17.28% / -1.41% |
| 2022-Q22/3 |
WinCBT / S&P -6.26% / -16.10% |
WinCBT / S&P 29.99% / 13.71% |
LoseCBT / S&P -356.25% / 11.04% |
| 2022-Q12/3 |
WinCBT / S&P 22.35% / -4.60% |
WinCBT / S&P 40.36% / 15.97% |
LoseCBT / S&P -187.89% / 42.23% |
| 2021-Q42/3 |
WinCBT / S&P 12.83% / 11.03% |
WinCBT / S&P 37.90% / 15.00% |
LoseCBT / S&P -144.19% / 96.40% |
| 2021-Q31/3 |
LoseCBT / S&P -11.39% / 0.58% |
WinCBT / S&P 30.41% / 10.77% |
LoseCBT / S&P -202.60% / 69.42% |
| 2021-Q22/3 |
WinCBT / S&P 9.17% / 8.55% |
WinCBT / S&P 13.73% / 6.58% |
LoseCBT / S&P -185.71% / 51.81% |
| 2021-Q11/3 |
WinCBT / S&P 17.64% / 6.17% |
LoseCBT / S&P -11.06% / -1.06% |
LoseCBT / S&P -243.02% / 7.39% |
| 2020-Q41/3 |
WinCBT / S&P 25.54% / 12.15% |
LoseCBT / S&P -18.81% / -3.72% |
LoseCBT / S&P -276.71% / -33.42% |
| 2020-Q30/3 |
LoseCBT / S&P -1.86% / 8.93% |
LoseCBT / S&P -21.67% / -2.04% |
LoseCBT / S&P -260.84% / -27.10% |
| 2020-Q21/3 |
WinCBT / S&P 43.17% / 20.54% |
LoseCBT / S&P -17.20% / -0.46% |
LoseCBT / S&P -68.80% / -27.11% |
| 2020-Q10/3 |
LoseCBT / S&P -44.54% / -19.60% |
LoseCBT / S&P -7.72% / 3.47% |
LoseCBT / S&P -59.68% / -14.75% |
| 2019-Q41/3 |
LoseCBT / S&P 5.63% / 9.07% |
LoseCBT / S&P -2.99% / 5.36% |
WinCBT / S&P 75.20% / 2.99% |
| 2019-Q30/3 |
LoseCBT / S&P -4.15% / 1.70% |
LoseCBT / S&P 2.93% / 5.02% |
LoseCBT / S&P -240.64% / 0.21% |
| 2019-Q22/3 |
WinCBT / S&P 15.58% / 4.30% |
WinCBT / S&P 7.87% / 6.64% |
LoseCBT / S&P -259.56% / 8.65% |
| 2019-Q11/3 |
LoseCBT / S&P -2.37% / 13.65% |
WinCBT / S&P 13.59% / 8.12% |
LoseCBT / S&P -252.05% / 14.29% |
| 2018-Q41/3 |
LoseCBT / S&P -31.07% / -13.52% |
WinCBT / S&P 18.29% / 9.05% |
LoseCBT / S&P 16.82% / 18.23% |
| 2018-Q31/3 |
LoseCBT / S&P 2.05% / 7.71% |
WinCBT / S&P 19.32% / 10.21% |
LoseCBT / S&P -147.83% / 19.06% |
| 2018-Q22/3 |
WinCBT / S&P 11.48% / 3.43% |
WinCBT / S&P 19.21% / 9.03% |
LoseCBT / S&P -163.03% / 14.46% |
| 2018-Q11/3 |
LoseCBT / S&P -9.08% / -0.76% |
WinCBT / S&P 17.28% / 7.68% |
LoseCBT / S&P -178.49% / 12.46% |
| 2017-Q42/3 |
WinCBT / S&P 10.95% / 6.64% |
WinCBT / S&P 16.83% / 7.03% |
LoseCBT / S&P -67.48% / 13.82% |
| 2017-Q33/3 |
WinCBT / S&P 5.07% / 4.48% |
WinCBT / S&P 12.69% / 5.68% |
WinCBT / S&P 68.53% / 17.57% |
| 2017-Q22/3 |
LoseCBT / S&P -10.26% / 3.09% |
WinCBT / S&P 6.09% / 4.83% |
WinCBT / S&P 66.82% / 17.74% |
| 2017-Q11/3 |
WinCBT / S&P 19.15% / 6.07% |
LoseCBT / S&P -0.28% / 3.67% |
LoseCBT / S&P -164.36% / 13.32% |
| 2016-Q40/3 |
LoseCBT / S&P -3.01% / 3.82% |
LoseCBT / S&P -9.13% / 2.09% |
LoseCBT / S&P -153.67% / 7.05% |
| 2016-Q31/3 |
WinCBT / S&P 15.48% / 3.85% |
LoseCBT / S&P -16.02% / 0.20% |
LoseCBT / S&P -143.53% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CBT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 5.63% | 20.78% |
| Annualized return | 5.63% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CBT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 75.75% | 83.14% |
| Annualized return | 11.94% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CBT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 114.29% | 319.30% |
| Annualized return | 7.92% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WD 40 CO (WDFC) | United States | $2.647B | 30.12 |
| FLOTEK INDUSTRIES INC/CN/ (FTK) | United States | $1.050B | 22.42 |
| ASP Isotopes Inc. (ASPI) | United States | $0.452B | -6.90 |
| Orion S.A. (OEC) | $0.341B | -3.89 | |
| Arq, Inc. (ARQ) | United States | $0.088B | -2.08 |
| FLEXIBLE SOLUTIONS INTERNATIONAL INC (FSI) | $0.075B | -27.31 | |
| Element Solutions Inc (ESI) | United States | $8.402B | 55.83 |